NCT01032200 · OUTCOME
HVLT-IR
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- LEAST_SQUARES_MEAN
- Unit
- number of correctly recalled words
- Interval / dispersion
- Standard Error
- Time frame
- 4 weeks post-RT
What was measured
HVLT-IR is the Hopkins Verbal learning test - immediate recall. Participants are given 12 words to remember. They are then asked to recall those words. This is repeated 3 times. Minimum recalled words 0 maximum 36. The HVLT-IR score is the sum of correctly recalled words across the three trials. Higher scores indicate better recall.
Analysis population: Participants with any data
Groups in this outcome
Arm I - Armodafinil
Patients receive oral armodafinil once daily beginning no later than the fifth fraction of brain radiotherapy and continuing for 9-11 weeks in the absence of unacceptable toxicity. Armodafinil: Given orally
Arm II - Placebo
Patients receive oral placebo once daily beginning no later than the fifth fraction of brain radiotherapy and continuing for 9-11 weeks in the absence of unacceptable toxicity. placebo: Given orally
| Group | Source count |
|---|---|
| Arm I - Armodafinil | 26 |
| Arm II - Placebo | 27 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Arm I - Armodafinil | 21.2 | 1.5 | Not reported | Not reported | Not reported |
| Arm II - Placebo | 20.0 | 1.4 | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- spread
- 1.5
- value
- 21.2
- group Id
- OG001
- spread
- 1.4
- value
- 20.0
- denoms
- counts
- group Id
- OG000
- value
- 26
- group Id
- OG001
- value
- 27
- units
- Participants
- description
- HVLT-IR is the Hopkins Verbal learning test - immediate recall. Participants are given 12 words to remember. They are then asked to recall those words. This is repeated 3 times. Minimum recalled words 0 maximum 36. The HVLT-IR score is the sum of correctly recalled words across the three trials. Higher scores indicate better recall.
- dispersion Type
- Standard Error
- groups
- description
- Patients receive oral armodafinil once daily beginning no later than the fifth fraction of brain radiotherapy and continuing for 9-11 weeks in the absence of unacceptable toxicity. Armodafinil: Given orally
- id
- OG000
- title
- Arm I - Armodafinil
- description
- Patients receive oral placebo once daily beginning no later than the fifth fraction of brain radiotherapy and continuing for 9-11 weeks in the absence of unacceptable toxicity. placebo: Given orally
- id
- OG001
- title
- Arm II - Placebo
- param Type
- LEAST_SQUARES_MEAN
- population Description
- Participants with any data
- reporting Status
- POSTED
- time Frame
- 4 weeks post-RT
- title
- HVLT-IR
- type
- SECONDARY
- unit Of Measure
- number of correctly recalled words
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle